Yanyu Wang

944 total citations · 1 hit paper
46 papers, 441 citations indexed

About

Yanyu Wang is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanyu Wang has authored 46 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 16 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanyu Wang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Yanyu Wang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Yanyu Wang collaborates with scholars based in China, United States and Taiwan. Yanyu Wang's co-authors include Haitao Zhao, Xinting Sang, Xiaobo Yang, Ziyu Xun, Pingshuan Dong, Junyu Long, Yunchao Wang, Yunchao Wang, Nan Zhang and Dongxu Wang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Yanyu Wang

45 papers receiving 438 citations

Hit Papers

Biomarkers and prognostic... 2024 2026 2024 10 20 30 40

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanyu Wang China 13 166 151 81 78 53 46 441
Xue Han China 13 129 0.8× 59 0.4× 168 2.1× 78 1.0× 120 2.3× 35 471
Weiwei Chen China 11 203 1.2× 68 0.5× 95 1.2× 63 0.8× 54 1.0× 43 445
Daniel Vasile Balaban Romania 15 112 0.7× 273 1.8× 44 0.5× 44 0.6× 22 0.4× 73 563
Muhammet Özer United States 13 106 0.6× 78 0.5× 41 0.5× 58 0.7× 18 0.3× 50 317
Yangfan Su China 5 81 0.5× 114 0.8× 72 0.9× 119 1.5× 39 0.7× 13 466
Valery Vilchez United States 11 147 0.9× 153 1.0× 224 2.8× 52 0.7× 101 1.9× 27 611
Megan Braunlin United States 8 101 0.6× 84 0.6× 113 1.4× 61 0.8× 73 1.4× 16 446
Caterina Mancusi Italy 12 113 0.7× 54 0.4× 111 1.4× 58 0.7× 28 0.5× 22 520
Ya Zheng China 12 94 0.6× 95 0.6× 160 2.0× 118 1.5× 121 2.3× 50 470

Countries citing papers authored by Yanyu Wang

Since Specialization
Citations

This map shows the geographic impact of Yanyu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanyu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanyu Wang more than expected).

Fields of papers citing papers by Yanyu Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanyu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanyu Wang. The network helps show where Yanyu Wang may publish in the future.

Co-authorship network of co-authors of Yanyu Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanyu Wang. A scholar is included among the top collaborators of Yanyu Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanyu Wang. Yanyu Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cai, Yuanqing, Yi Chen, Yanyu Wang, et al.. (2025). Fabrication of GDNF-Gel/HA-Mg nerve conduit and its role in repairing peripheral nerve defects. Materials Today Bio. 32. 101764–101764. 3 indexed citations
2.
Zhang, Nan, Yang Xu, Ziyu Xun, et al.. (2024). Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinoma. Biomarker Research. 12(1). 26–26. 43 indexed citations breakdown →
3.
Li, Yujia, et al.. (2024). The effect of aromatherapy on post-stroke depression: study protocol for a pilot randomized controlled trial. Frontiers in Psychiatry. 15. 1428028–1428028. 1 indexed citations
4.
Petrick, Jessica L., Andrea A. Florio, Yanyu Wang, et al.. (2023). Biomarkers of gut barrier dysfunction and risk of hepatocellular carcinoma in the REVEAL‐HBV and REVEAL‐HCV cohort studies. International Journal of Cancer. 153(1). 44–53. 5 indexed citations
5.
Zhang, Longhao, Jingnan Xue, Nan Zhang, et al.. (2023). The efficacy and safety of bevacizumab as a salvage therapy for patients with advanced hepatocellular carcinoma targeting immune tolerance.. PubMed. 13(8). 3582–3590. 2 indexed citations
6.
Tang, Yanyan, et al.. (2022). Association between oral infections, triglyceride‐glucose index, and in‐stent restenosis. Oral Diseases. 29(8). 3698–3706. 6 indexed citations
7.
Wang, Yunchao, Xiaobo Yang, Dongxu Wang, et al.. (2022). Lenvatinib Beyond First-Line Therapy in Patients With Advanced Biliary Tract Carcinoma. Frontiers in Oncology. 12. 785535–785535. 17 indexed citations
8.
Wang, Yanyu, Shan Wei, Rong Zhou, et al.. (2021). The Relationships Between Lipid Accumulation Product Levels and Cognitive Decline Over 4 Years in a Rural Area of Xi’an, China. Frontiers in Aging Neuroscience. 13. 761886–761886. 2 indexed citations
9.
Song, Yang, Ziqi Jia, Yadong Wang, et al.. (2020). Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q. Journal of Thoracic Disease. 12(5). 2771–2780. 5 indexed citations
10.
Ma, Wenzhi, et al.. (2019). 4D-QSAR and MIA-QSAR study on the Bruton's tyrosine kinase (Btk) inhibitors. Journal of Molecular Graphics and Modelling. 92. 357–362. 20 indexed citations
12.
Wang, Yanyu, Wen‐Lian Chen, Xiangqin Weng, et al.. (2017). Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34 + Acute Myeloid Leukemia. Stem Cells and Development. 26(20). 1460–1467. 12 indexed citations
14.
Wang, Chuang, Shaoxin Wang, Pingshuan Dong, et al.. (2015). Pathological observation of acute myocardial infarction in Chinese miniswine.. PubMed. 8(11). 20829–36. 2 indexed citations
15.
Wang, Yanyu, Pingshuan Dong, Ling Li, et al.. (2014). Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Drug-Eluting Stents for Patients With Coronary Artery Disease: An Update Meta-Analysis. Cardiovascular Drugs and Therapy. 28(4). 379–385. 9 indexed citations
16.
Wang, Yanyu, Pingshuan Dong, Ling Li, et al.. (2013). The mitochondrial tRNAMet4454T > C variant may not be associated with essential hypertension in Han Chinese population. Mitochondrial DNA. 25(2). 124–125. 7 indexed citations
17.
Wang, Yanyu, et al.. (1996). Peptides derived from IgE heavy chain constant region induce profound IgE isotype‐specific tolerance. European Journal of Immunology. 26(5). 1043–1049. 5 indexed citations
18.
Wang, Yanyu, et al.. (1996). Nucleophile Labeling of Cysteine and Serine Protease Substrates. Journal of Biological Chemistry. 271(45). 28399–28406. 1 indexed citations
19.
Schmaltz, Robert, et al.. (1996). Inhibition of Antigen-Specific IgE Production by Antigen Coupled to Membrane IgE Peptide. Immunological Investigations. 25(5-6). 495–505. 1 indexed citations
20.
Schmaltz, Robert, et al.. (1995). Staphylococcal Enterotoxin is a Bovine T Cell Superantigen. Immunological Investigations. 24(5). 805–818. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026